Skip to main content
Premium Trial:

Request an Annual Quote

Arrowhead Releases HBV White Paper

Premium

Arrowhead Research this week released a white paper detailing the market potential for a hepatitis B therapy and the use of its dynamic polyconjugate siRNA-delivery technology to attack the virus.

The white paper can be found here.

"The development of a ... HBV candidate began under Roche and we are very pleased with the progress that our scientists have made," David Lewis, vice president of biology at Arrowhead, said in a statement.

He added that additional information about Arrowhead's HBV program, which was announced last month (GSN 2/16/2012), will be made public at upcoming scientific conferences and in peer-reviewed papers.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.